CoChat

3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies

Open access
Gunness, Patrina, Mueller, Daniel, Shevchenko, Valery, Heinzle, Elmar, Ingelman-Sundberg, Magnus, Noor, Fozia · 2013 · Toxicological Sciences

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Drug-induced human hepatotoxicity is difficult to predict using the current in vitro systems. In this study, long-term 3D organotypic cultures of the human hepatoma HepaRG cell line were prepared using a high-throughput hanging drop method. The organotypic cultures were maintained for 3 weeks and assessed for (1) liver specific functions, including phase I enzyme and transporter activities, (2) expression of liver-specific proteins, and (3) responses to three drugs (acetaminophen, troglitazone, and rosiglitazone). Our results show that the organotypic cultures maintain high liver-specific functionality during 3 weeks of culture. The immunohistochemistry analyses illustrate that the organotypic cultures express liver-specific markers such as albumin, CYP3A4, CYP2E1, and MRP-2 throughout the cultivation period. Accordingly, the production rates of albumin and glucose, as well as CYP2E1 activity, were significantly higher in the 3D versus the 2D cultures. Toxicity studies show that the organotypic cultures are more sensitive to acetaminophen- and rosiglitazone-induced toxicity but less sensitive to troglitazone-induced toxicity than the 2D cultures. Furthermore, the EC50 value (2.7mM) for acetaminophen on the 3D cultures was similar to in vivo toxicity. In summary, the results from our study suggest that the 3D organotypic HepaRG culture is a promising in vitro tool for more accurate assessment of acute and also possibly for chronic drug-induced hepatotoxicity.

Overview

Integrity signals

Registry

Crossref · 10.1093/toxsci/kft021

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Watanabe, (1999), Was it not possible to predict liver dysfunction caused by troglitazone during the nonclinical safety studies?, Reevaluat. Safe, 30, 537

Cited by

See all 236

Metadata

Authors
Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F.
Affiliations
  • Karolinska Institutet (SE)
  • Saarland University (DE)
Venue
Toxicological Sciences
Published
2013-02-01
Volume
133
Issue
1
Pages
67-78
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2143495342
Cited by
236
References
73
Citations by year
2026: 9 · 2025: 7 · 2024: 15 · 2023: 6 · 2022: 16 · 2021: 18 · 2020: 25 · 2019: 23 · 2018: 23 · 2017: 23 · 2016: 24 · 2015: 20 · 2014: 22 · 2013: 5
FWCI
25.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Toxicological Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
Funders
McGill University
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
HepaRG cells, 3D organotypic culture, drug-induced liver injury, acetaminophen toxicity, rosiglitazone, troglitazone, CYP2E1, CYP3A4, MRP2, albumin synthesis, phase I enzymes, drug transporters, in vitro toxicity testing, hanging drop method
MeSH terms
Cytochrome P450 Family 2, Rosiglitazone, Troglitazone, Acetaminophen, Multidrug Resistance-Associated Protein 2, ATP-Binding Cassette Sub-Family B Member 4, Albumins, Chromans, Cytochrome P-450 Enzyme System, Humans, Liver, Urea, ATP Binding Cassette Transporter, Subfamily B, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Toxicity Tests, Acute, Thiazolidinediones, Cell Line, Tumor, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.